Articles

Improvement of Paulomycin Stability by Addition of Paulic Acid

  • Tang Yue ,
  • Wang Min ,
  • Ding Yong ,
  • Li Jine ,
  • Chen Yihua
Expand
  • a State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101;
    b University of Chinese Academy of Sciences, Beijing 100049

Received date: 2018-05-28

  Revised date: 2018-06-22

  Online published: 2018-07-05

Supported by

Project supported by the National Natural Science Foundation of China (No. 31670032 & 31522001).

Abstract

Paulomycins are a group glycoside antibiotics produced by Streptomyces, which not only show excellent antibacterial activities against gram-positive bacteria, but also display good antitumor activities. The paulic acid moiety is one of the structures that cause the instability of paulomycin. This study aimed to improve the stability of paulomycins. When small molecule thiol compound N-acetylcysteamine (SNAC) was added to the fermentation broth of paulmycin producing strain, four new paulomycin derivatives of palsimycins A, B, C, and D were obtained. The antibacterial activity evaluation showed that the minimal inhibit concentrations (MICs) of palsimycin A and palsimycin B against the tested strains were at the same level as those of paulomycin A and paulomycin B. The stability test revealed that under the same conditions, palsimycin A, B, C, and D were all more stable than paulomycin A and paulomycin B. In conclusion, without scarifying the antibacterial activity, this study increased the stability of paulomycin by the addition of paulic acid with SNAC, which laid a foundation for further research and application of paulomycins.

Cite this article

Tang Yue , Wang Min , Ding Yong , Li Jine , Chen Yihua . Improvement of Paulomycin Stability by Addition of Paulic Acid[J]. Chinese Journal of Organic Chemistry, 2018 , 38(9) : 2420 -2426 . DOI: 10.6023/cjoc201805045

References

[1] Wiley, P. F.; Mizsak, S. A.; Baczynskyj, L.; Argoudelis, A. D. J. Antibiot. 1984, 37, 1273.
[2] Argoudelis, A. D.; Baczynskyj, L.; Mizsak, S. A.; Shilliday, F. B.; Wiley, P. F. J. Antibiot. 1988, 41, 1316.
[3] Sanchez, M. S.; Ford, C. W. Antimicrob. Agents Chemother. 1986, 29, 634.
[4] Tsukiura, H.; Okanishi, M.; Koshiyama, H.; Ohmori, T.; Miyaki, T.; Kawaguchi, H. J. Antibiot. 1964, 17, 223.
[5] Hanka, L. J.; Dietz, A. J. Antibiot. 1976, 29, 611.
[6] Mitscher, L. A.; Mccrae, W.; Devoe, S. E.; Shay, A. J.; Hausmann, W. K.; Bohonos, N. Antimicrob. Agents Chemother. 1965, 5, 828.
[7] Argoudelis, A. D.; Baczynskyj, L.; Haak, W. J.; Knoll, W. M.; Mizsak, S. A.; Shilliday, F. B. J. Antibiot. 1988, 41, 157.
[8] Argoudelis, A. D.; Baczynskyj, L.; Mizsak, S. A.; Shilliday, F. B.; Spinelli, P. A. J. Antibiot. 1987, 40, 419.
[9] Majer, J.; Chater, K. F. J. Gen. Microbiol. 1987, 133, 2503.
[10] Olano, C.; García, I.; González, A.; Rodriguez, M.; Rozas, D.; Rubio, J. Microb. Biotechnol. 2014, 7, 242.
[11] Hoz, J. F.; Méndez, C.; Salas, J. A.; Olano, C. Molecules 2017, 22, 1758.
[12] Li, J.; Wang, M.; Ding, Y.; Tang, Y.; Zhang, Z.; Chen, Y. Sci. Rep. 2016, 6, 21180.
[13] Guo, Z.; Li, J.; Qin, H.; Wang, M.; Lv, X.; Chen, Y. Angew. Chem. Int. Ed. 2015, 127, 5264.
[14] Li, J.; Xie, Z.; Wang, M.; Ai, G.; Chen, Y. PLoS One 2015, 10, e0120542.
[15] Cheng, L.; Liao, G.; Zhang, J.; Tan, H. Microb. Cell Fact. 2015, 14, 173.

Outlines

/